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Purpose: We aimed to investigate the detection of nanobacteria (NB) from expressed 
prostatic secretions (EPS) in patients with category III chronic prostatitis/chronic pel-
vic pain syndrome (CP/CPPS) and from vaginal swabs in patients with vaginitis by re-
verse transcriptase polymerase chain reaction (RT-PCR) and to evaluate the associa-
tion between NB and Neisseria gonorrhea, Chlamydia trachomatis, Ureaplasma ure-
alyticum (U. urealyticum), Mycoplasma hominis, Trichomonas vaginalis, and Myco-
plasma genitalium. 
Materials and Methods: A group of 11 men attending a specialized CP/CPPS clinic and 
a group of 157 women who reported symptoms of lower genital tract infection were en-
rolled in this study. NB were detected by RT-PCR. A Seeplex Sexually Transmitted 
Disease Detection assay (Seegene Inc., Seoul, Korea) was used that could detect DNA 
for 6 types of sexually transmitted pathogens.
Results: In EPS samples, the detection rate of NB in patients with CP/CPPS was 9.1%, 
and 9 (5.7%) of 157 vaginitis patients showed positive results in RT-PCR for NB in vagi-
nal swabs. Associations observed among the 7 microorganisms included 6 (54.5%) pa-
tients who tested positive on EPS and 75 (47.8%) patients who tested positive on vaginal 
swabs. Five patients with vaginitis were found to have monoinfection of NB (6.7%). 
Conclusions: We found that conventional RT-PCR for NB was rapid, simple, low in cost, 
and easily available for the detection of NB, and that NB may be a possible etiological 
factor for vaginitis and CP/CPPS. The prevalence of U. urealyticum among the four pa-
tients with NB coinfection was 75%; the presence of U. urealyticum might therefore 
raise suspicion for nanobacterial infection. 
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INTRODUCTION
Category III chronic prostatitis/chronic pelvic pain syn-
drome (CP/CPPS) is the category with the highest in-
cidence, accounting for 60% to 90% of those with prostatitis 
[1]. Bacterial pathogens have not been found in prostatic 
tissue, urine, or prostatic fluid by conventional culture; 
however, prostatic inflammation and inflammatory mark-
ers are often identified [2]. This suggests the existence of 
yet unknown infectious pathogens and the importance of 
identifying these pathogens for the diagnosis and treat-
ment of type III prostatitis. 
　The female genital tract represents a highly dynamic en-
vironment, with a resident microflora consisting of a varie-
ty of different species. The coexistence of different sexually 
transmitted microorganisms is very common and is due to 
several factors, including a common route of transmission, 
the sexual behavior of the host, and the resident flora [3]. 
Infectious vaginitis accounts for 90% of all cases in women 
of reproductive age and is represented by the triad of candi-
diasis, bacterial vaginosis, and trichomoniasis. Other less 
common infections are caused by gonorrhea, chlamydia, Korean J Urol 2011;52:194-199
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mycoplasma, herpes, campylobacter, and some parasites. 
Vaginal infections are often (varies between 20% and 40% 
of vaginal infections) a mix of various etiologies, which 
presents challenges for treatment. Indeed, when only one 
cause is treated, the other pathogens can gain resistance 
and induce relapses and recurrences. Therefore, the key 
factor is to obtain a precise diagnosis and to provide treat-
ment with a broad-spectrum anti-infective.
　Nanobacteria (NB) are newly discovered infectious 
agents of 100-500 nm in size with a 16S ribosomal RNA 
(rRNA) gene sequence and slow growth and a doubling time 
of about 3 days [4]. They are fastidious and difficult to cul-
ture but can be detected with standard microbiological 
methods [5-7]. In vivo, NB are found to be voided mainly 
through the urinary system, and they have been isolated 
within the genitourinary tract, including in polycystic dis-
ease, renal calculi, and chronic prostatitis [2]. Further-
more, nanobacterial infection of malignant ovarian tissue 
contributes to mechanisms leading to the formation of cal-
cified deposits known as psammoma bodies [8]. 
　In this study, we aimed to investigate the detection of NB 
from expressed prostatic secretions (EPS) in patients with 
CP/CPPS and from vaginal swabs in patients with vagi-
nitis by reverse transcriptase polymerase chain reaction 
(RT-PCR) and to evaluate the association between NB and 
Neisseria gonorrhea (N. gonorrhea), Chlamydia trachoma-
tis (C. trachomatis), Ureaplasma urealyticum (U. urealyti-
cum), Mycoplasma hominis (M. hominis), Trichomonas 
vaginalis (T. vaginalis), and Mycoplasma genitalium (M. 
genitalium).
MATERIALS AND METHODS
1. Sample collection 
A group of 11 men attending a specialized CP/CPPS clinic 
of the Urology Department of the hospital (mean age, 43.5 
years) were enrolled in the study. Prostatic fluid samples 
were collected from outpatients with refractory type IIIB 
prostatitis by aseptic technique by use of the Mearses- 
Stamey four glass urine collection method. All patients 
must have abstained from sexual activity for at least 4 days 
before sample collection. The urethral orifice was dis-
infected with benzalkonium chloride. Symptoms were 
quantified by the National Institutes of Health Chronic 
Prostatitis Symptom Index (NIH-CPSI) [9]. All patients 
had a complete history, physical examination, wet mount 
examination, urine culture, and EPS. Because the routine 
culture results of the first voided bladder specimen, second 
midstream bladder specimen, EPS, and urine sample after 
prostatic massage were negative, we could exclude cystitis 
and urethritis. The control group included 5 healthy men 
(mean age, 40.9 years) without symptoms. A group of 157 
women of reproductive age attending the Obstetrics and 
Gynecology Department of the same hospital (mean age, 
38 years) were enrolled in this study. All women reported 
symptoms of lower genital tract infection (vaginal dis-
charge or vulvar or vaginal complaints). Three cotton swabs 
were obtained from the posterior vaginal fornix of each 
patient. Twenty-nine healthy women (mean age, 39.7 
years) without symptoms of lower genital tract infection 
who visited the Hospital Health Center were selected as a 
control group. The Institutional Review Board approved 
this study.
2. RNA/DNA isolation 
For RNA/DNA isolation, a QIAamp RNA/DNA mini kit 
(Qiagen, Hilden, Germany) was used according to the man-
ufacturer’s instructions. Vaginal swabs and EPS specimens 
were swirled in lysis buffer containing 1% Triton X-100, 
0.5% Tween 20, and 1 mmol EDTA. After mixing the sam-
ples with 200 μl buffer AL (Qiagen) and 20 μl proteinase 
K, the samples were incubated for 30 min at 56
oC followed 
by 15 min at 95
oC. For synthesis of cDNA, reverse tran-
scription was carried out by using the Reverse AIDTM First 
Strand cDNA Synthesis Kit (Fermentas, Burlington, 
Canada). Pre-PCR products were stored at −20
oC until 
use. 
3. Reverse transcriptase polymerase chain reaction for 
nanobacteria
　1) Reverse transcriptase of nanobacteria: Ten micro-
liters of each bacterial RNA was denatured at 80
oC for 3 
min; mixed with a master mix consisting of 4 μl of 5x RT- 
buffer, 2 μl of dNTPs, 1 μl of RNase inhibitor, 1 μl of reverse 
random primer, 1 μl dithiothreitol (DTT), and 1 μl of reverse 
transcriptase; and incubated for 90 min at 37
oC. After in-
activation of reverse transcriptase by incubation at 94
oC 
for 2 min, cDNAs were processed immediately for amplif-
ication. 
　2) Polymerase chain reaction of nanobacteria: cDNAs (3 
μl) were mixed with a PCR premix consisting of 10x PCR 
buffer, 1 μl of forward primer (5'-acaatggtggtgacagtggg-3'), 
and 1 μl of reverse primer (5'-cgggtaaaaccaactcccat-3') 
(Table 1). Forty cycles were carried out at 94
oC for 30 s and 
60
oC and 72
oC, each for 90 s. Then the PCR mix (10 μl) was 
subjected to 4% agarose gel electrophoresis at 100 V for 30 
min and nucleic acid bands were visualized by ethidium 
bromide staining. 
4. Multiplex PCR for sexually transmitted disease 
A multiplex PCR has been designed for simultaneous de-
tection of N. gonorrhea, C. trachomatis, U. urealyticum, M. 
hominis, T. vaginalis, and M. genitalium. The Seeplex 
Sexually Transmitted Disease Detection assay (Seegene 
Inc., Seoul, Korea) uses two separate primer mixes and can 
detect the DNA for 6 types of sexually transmitted patho-
gens (Table 1).
5. Statistical analysis 
Differences in proportions were assessed by 2-tailed 
Fisher’s exact tests. Any p-value less than 0.05 was consid-
ered statistically significant. The software package SPSS 
ver. 14.0 (SPSS Inc., Chicago, IL, USA) was used.Korean J Urol 2011;52:194-199
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TABLE 1. Target for detection of seeplex sexually transmitted disease detection assay by multiplex PCR assays and conventional 
primers for nanobacteria by RT-PCR
Target Accession number Amplication size (bp)
Seeplex STD detection assay
Arabidopsis (internal control) Cesa3 719
Neisseria gonorrhea  PorA pseudogene AJ223447 580
Chlamydia trachomati  pCTT1 M19487 253
Ureaplasma urealyticum UreG-D AF085729 348, 435, 502
Mycoplasma hominis Gap AJ243692 214
Trichomonas vaginalis  Beta-tubulin I L05468 435
Mycoplasma genitalium GyrA L43967 502
Sequence primers
Nanobacteria Forward 5‘-acaatggtggtgacagtggg-3' 208
Reverse 5’-cgggtaaaaccaactcccat-3'
PCR:  polymerase chain reaction, RT-PCR:  reverse transcriptase polymerase chain reaction, STD: sexually transmitted disease, bp:
base pair
FIG. 1. Reverse transcriptase polymerase chain reaction for 
nanobacteria. M: size marker, Pt: patient with vaginitis, NC: 
negative control, bp: base pair.
TABLE 2. Frequency of single and co-infections of N. gonorrhea, 
C. trachomatis, U. urealyticum, M. hominis, T. vaginalis, M. 
genitalium, and nanobacteria in EPS of 6 men with organisms
Organism No. of positives Percent
1 microorganism
N. gonorrhea  11 6 . 7
C. trachomatis 23 3 . 3
U. urealyticum 11 6 . 7
M. genitalium 11 6 . 7
Subtotal 5 83.3
2 microorganisms
C. trachomatis＋nanobacteria 1 16.7
Subtotal 1 16.7
Total 6 100
EPS: expressed prostatic secretions
RESULTS
1. Detection of nanobacteria by RT-PCR 
In order to detect nanobacterial RNA in EPS and vaginal 
swabs, RT-PCR was performed with primers specifically 
designed for direct detection of nanobacterial genomic 
elements. Fig. 1 shows the results of agarose gel electro-
phoresis of RT-PCR products (band at 208 bp). In EPS sam-
ples, the detection rate of NB in patients with CP/CPPS was 
9.1%, and all of the 5 healthy volunteers were negative. 
There was no significant difference in the detection rate of 
NB by RT-PCR between the two groups (p=0.48). Nine 
(5.7%) of 157 vaginitis patients who showed positive re-
sults on RT-PCR for NB in vaginal swabs and all of the 29 
healthy volunteers were negative. There was no significant 
difference in the detection rate of NB by RT-PCR between 
the two groups (p=0.19). 
2. Association of N. gonorrhea, C. trachomatis, U. ure-
alyticum, M. hominis, T. vaginalis, M. genitalium, and 
nanobacteria
A total of 11 patients with CP/CPPS were included in the 
study. Six patients (54.5%) tested positive on EPS. The as-
sociations observed among the 7 microorganisms in the 
group of symptomatic men analyzed are summarized in 
Table 2. Monoinfection was detected in 5 of 6 positive pa-
tients (65.3%). The majority of monoinfections were C. 
trachomatis. One patient was co-infected with two organ-
isms (16.7%). NB were co-infected with C. trachomatis.
　A total of 157 vaginitis patients were included in the 
study. Seventy-five patients (47.8%) tested positive on vag-
inal swabs. The associations observed among the 7 micro-
organisms in the group of symptomatic women analyzed 
are summarized in Table 3. Monoinfection was detected in 
49 of 75 positive patients (65.3%). The majority of mono-
infections were C. trachomatis and U. urealyticum. Nine-
teen patients were co-infected with two organisms (25.3%), 
5 patients were co-infected with three organisms (6.7%), 
and 2 patients were co-infected with 4 organisms (2.7%). Korean J Urol 2011;52:194-199
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TABLE 3. Frequency of single and co-infections of N. gonorrhea, 
C. trachomatis, U. urealyticum, M. hominis, T. vaginalis, M. 
genitalium, and nanobacteria in vaginal swabs of 75 women 
with organisms
Organism No. of positives Percent
1 microorganism
N. gonorrhea  22 . 7
C. trachomatis  56 . 7
U. urealyticum 17 22.7
M. hominis 16 21.3
T. vaginalis  11 . 8




U. urealyticum＋N. gonorrhea 11 . 8
U. urealyticum＋M. hominis 8 10.7
U. urealyticum＋nanobacteria 2 2.7
U. urealyticum＋C. trachomatis 22 . 7
C. trachomatis＋T. vaginalis 11 . 8
C. trachomatis＋M. hominis 34 . 0




 nanobacteria 1 1.8
C. trachomatis＋T. vaginalis＋
 M. hominis 11 . 8
U. urealyticum＋M. hominis＋
 nanobacteria 1 1.8
C. trachomatis＋M. genitalium＋
 M. hominis 11 . 8
U. urealyticum＋N. gonorrhea＋
 M. hominis 11 . 8
Subtotal 5 6.7
4 microorganisms
U. urealyticum＋N. gonorrhea＋ 11 . 8
 M. genitalium＋C. trachomatis
U. urealyticum＋N. gonorrhea＋ 11 . 8
 M. hominis＋C. trachomatis
Subtotal 2 2.7
Total 75 100
Our data demonstrate the association in vivo between 
monoinfection of nanobacteria and vaginitis (6.7%). NB 
were co-infected with C. trachomatis, U. urealyticum, and 
M. hominis.
DISCUSSION
NB have recently been described as novel microorganisms 
characterized by a small size (0.2 to 0.5 μ) with a 16S rRNA 
gene sequence and slow growth and a doubling time of 
about 3 days. They are gram-negative, have a unique struc-
ture and apparent nucleic acid, and their growth in vitro 
is best inhibited by tetracycline [10]. NB exist in blood, 
urine, and other organs and tissues [2]. Raoult et al and 
Young et al thought that NB were mineral-fetuin com-
plexes or pleomorphic mineralo-protein complexes [11,12]; 
nevertheless, they could not exclude the possibility that NB 
are pathogenic microorganisms. In the clinical situation, 
NB may initiate kidney stone formation [5]. They have been 
found in periodontal disease [13], calcified human valves 
[4], and in urine and bladder tissue samples of patients with 
interstitial cystitis/painful bladder syndrome [14] and 
have been shown to participate in the clinical pathological 
process of those diseases. 
　In addition to the culture method, several other diag-
nostic tools have been developed for identification of NB. 
One of the most powerful methods is transmission electron 
microscopy (TEM); however, this method requires very ex-
pensive equipment. Conventional NB culture and anti-
genic detection do not require expensive equipment; how-
ever, these methods are often time consuming with cum-
bersome procedures. For DNA sequencing, genomic RNA 
is isolated from NB cultures, which is similar to the above 
methods. Therefore, we developed a primer for conven-
tional RT-PCR, which makes it possible to find NB from un-
cultured direct specimens. This method was superior to 
TEM, conventional NB culture, and DNA sequencing of iso-
lated NB cultures. Our method was rapid, simple, low in 
cost, and easily available because of the use of uncultured 
specimens and conventional RT-PCR. 
　Zhou et al found a 62.5% and 12.5% NB-positive rate in 
cultured EPS and urine samples, respectively, after pro-
static massage in men with type III prostatitis [7]. Another 
study found indirect evidence of NB on antigen and anti-
body by using enzyme-linked immunosorbent assay 
(ELISA) in 40% of urine samples and 0% of EPS in patients 
with CP/CPPS [15]. Shen et al postulated that the patho-
genesis of prostatic calculi involves a certain mechanism: 
1) NB form calcifications and mineral deposition cores; 2) 
the prostatic epithelial membrane is damaged by nano-
bacterial infection, causing exposure of tissue components 
that may form crystal cores; 3) NB mix with prostatic secre-
tions; 4) with urine backflow, high metabolite concen-
trations result. Shen et al concluded that NB might be an 
important etiological factor for type III prostatitis [16]. In 
our 11 direct EPS samples, the detection rate of NB in pa-
tients with CP/CPPS was 9.1% and NB were co-infected 
with C. trachomatis. C. trachomatis was most commonly 
detected with CP/CPPS and the frequency of co-infection 
with NB was higher than that for other infectious 
organisms. In our study, the NB-positive rate in direct EPS 
was lower than 62.5% with cultured EPS and higher than 
0% with the ELISA method. In our opinion, because we 
used only the direct EPS samples, and not cultured EPS 
samples, the NB-positive rate was low. The culture method 
showed a high positive rate but required a minimum of 5 
weeks and had opportunity for contamination. The ELISA 
method for detection of antibody showed a positive rate 
that was too low. RT-PCR for NB has the advantages of be-
ing rapid, simple, low in cost, and easily available. The se-
quences obtained were confirmed as NB by comparison Korean J Urol 2011;52:194-199
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with those in the GenBank (National Center for Biotech-
nology Information) database by using the Basic Local 
Alignment Search Tool (BLAST). However, when applying 
molecular assays as a routine diagnostic test, one should 
be aware of false-positives resulting from the amplified 
method. Also, clinical diagnosis by PCR only may be in-
accurate, because vaginitis and prostatitis caused by NB 
cannot be distinguished from that caused by the normal 
flora and contamination, and the positive results of PCR 
are not always the cause of the disease.
　According to current opinion, type III prostatitis is prob-
ably related to nanobacterial infection, mainly because NB 
have been shown to cause multiple organic infections, espe-
cially urologic infections. Also, after anti-NB treatment, 
the NB-positive rate decreased significantly, and the pa-
tients’ symptoms resolved [7]. It is important that we pre-
cisely identify the cause of infection and provide the correct 
treatment. Therefore, we attempted to develop a rapid, 
simple, low-cost, and easily available method for use with 
uncultured specimens.
　Vaginal infection encompasses a broad range of symp-
toms, ranging from a state of severe inflammation and irri-
tation with a frothy malodorous discharge, pain, and dys-
pareunia to an asymptomatic carrier state, which is esti-
mated to constitute up to 50% of cases [17]. Infections by 
U. urealyticum, M. hominis, and T. vaginalis during preg-
nancy can lead to premature rupture of the placental mem-
branes, premature labor, and low-birth-weight infants 
[18]. In this study, 9 (5.7%) of 157 vaginitis patients showed 
positive results in RT-PCR for NB in vaginal swabs and all 
of the 29 healthy volunteers were negative. There was no 
significant difference in the detection rate for NB by 
RT-PCR between the two groups (p=0.19). However, we 
found five patients who were not positive for N. gonorrhea, 
C. trachomatis, U. urealyticum, M. hominis, T. vaginalis, 
or M. genitalium who were only infected with NB. Our data 
suggest that nanobacteria may be an etiological factor for 
vaginitis. The prevalence of U. urealyticum among the four 
patients with NB co-infection was 75%; the presence of U. 
urealyticum might raise suspicion for nanobacterial 
infection. A symbiotic association between NB and U. ure-
alyticum was implied; however, the number of subjects 
co-infected with NB was too small, which was a limitation 
of the study. Unfortunately, physicians could not de-
termine whether nanobacteria were the cause of infection 
because it would take too much time to detect the nano-
bacteria and it would not result in appropriate treatment.
　Although the controversies about whether NB are living 
organisms are continuing, the results of our study suggest 
that conventional RT-PCR for NB is rapid, simple, low in 
cost, and easily available for the detection of NB and that 
NB may be an etiological factor for vaginitis and prostatitis. 
However, there were several limitations to our study. First, 
there were a significant number of patients, both with 
CP/CPPS and vaginitis, for whom the positive results of NB 
testing were not available. Second, we could not compare 
our results with the results of the culture method and TEM. 
Finally, we did not attempt to correlate the clinical pre-
sentation of our patients with their test results. It was not 
the purpose of our study.
CONCLUSIONS
We found that conventional RT-PCR for NB was rapid, sim-
ple, low in cost, and easily available for the detection of NB 
and that NB may be a possible etiological factor for vagi-
nitis and CP/CPPS. The prevalence of U. urealyticum 
among the four patients with NB co-infection was 75%; the 
presence of U. urealyticum may therefore raise suspicion 
for nanobacterial infection. Physicians may want to consid-
er NB as the cause of infection and attempt to provide treat-
ment with an appropriate drug. 
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